Brief: YZi Labs Responds To Adoption Of Poison Pill And Defensive Bylaw Amendments By CEA Industries
05/01/2026 14:12
Jan 5 (Reuters) - CEA Industries Inc BNC.O: YZI LABS RESPONDS TO ADOPTION OF POISON PILL AND DEFENSIVE BYLAW AMENDMENTS BY CEA INDUSTRIES YZILABS: REVIEWING THE RECENT ACTIONS TAKEN BY BNC IN RESPONSE TO YZI’S GROUP FORMATION AND LAUNCH OF A CONSENT SOLICITATION PROCESS YZILABS: “HAS NEVER CONSIDERED AN ALTERNATIVE TOKEN FOR THE COMPANY’S DIGITAL ASSET TREASURY STRATEGY, NOR LAUNCHED COMPETITIVE DAT VENTURES" Source text: ID:nGNX2nLxvm Further company coverage: BNC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BNB Standard
See all newsBrief: CEA Industries - Q1 Net Loss $11.40 Million, Or $0.22 Per Share
Brief: Cea Industries - Files Complaint Against 10X Capital Over Asset Management Agreement
Brief: Cea Industries Provides Update On Status Of Renegotiation Of Asset Management Agreement With 10X Capital
Brief: Cea Industries (BNC) Reports FY Q3 2026 Earnings Results Announces CEO Transition
Brief: CEA Industries Confirms Receipt Of Letter Requesting Board Set A Record Date In Connection With Yzi Labs’ Consent Solicitation